NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Exact Sciences Corporation (NASDAQ: EXAS)

 
EXAS Technical Analysis
5
As on 1st Aug 2025 EXAS SHARE Price closed @ 47.76 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 58.09 & Strong Sell for SHORT-TERM with Stoploss of 63.01 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

EXASSHARE Price

Open 46.58 Change Price %
High 47.94 1 Day 0.81 1.73
Low 46.50 1 Week -0.65 -1.34
Close 47.76 1 Month -4.58 -8.75
Volume 2535254 1 Year -11.69 -19.66
52 Week High 74.26 | 52 Week Low 40.31
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
NVDA 173.72 -2.33%
OPEN 2.10 14.13%
EQ 0.71 82.05%
AMZN 214.75 -8.27%
NCNA 0.04 0.00%
LMDX 0.02 0.00%
BTAI 1.37 4.58%
AKTS 0.04 0.00%
AAPL 202.38 -2.50%
 
NASDAQ USA Top Gainers Stocks
MRIN 3450.00 383233.34%
MRIN 3450.00 383233.34%
HCTI 4.75 15733.33%
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
ORGS 1.00 1566.67%
REDU 3.41 1075.86%
DRMA 6.45 940.32%
CTXRW 0.14 600.00%
NBSTU 12.99 220.74%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
BPTH 0.21 -66.67%
AXDX 0.03 -66.67%
TFFP 0.06 -62.50%
OTRKP 0.02 -60.00%
HEPA 0.05 -58.33%
 
 
EXAS
Daily Charts
EXAS
Intraday Charts
Whats New @
Bazaartrend
EXAS
Free Analysis
 
EXAS Important Levels Intraday
RESISTANCE50.53
RESISTANCE49.64
RESISTANCE49.09
RESISTANCE48.54
SUPPORT46.98
SUPPORT46.43
SUPPORT45.88
SUPPORT44.99
 
EXAS Forecast August 2025
4th UP Forecast77.76
3rd UP Forecast68.14
2nd UP Forecast62.19
1st UP Forecast56.25
1st DOWN Forecast39.27
2nd DOWN Forecast33.33
3rd DOWN Forecast27.38
4th DOWN Forecast17.76
 
EXAS Weekly Forecast
4th UP Forecast58.19
3rd UP Forecast54.84
2nd UP Forecast52.78
1st UP Forecast50.71
1st DOWN Forecast44.81
2nd DOWN Forecast42.74
3rd DOWN Forecast40.68
4th DOWN Forecast37.33
 
EXAS Forecast2025
4th UP Forecast124.17
3rd UP Forecast99.66
2nd UP Forecast84.52
1st UP Forecast69.37
1st DOWN Forecast26.15
2nd DOWN Forecast11
3rd DOWN Forecast-4.14
4th DOWN Forecast-28.65
 
 
EXAS Other Details
Segment EQ
Market Capital 16636064768.00
Sector Healthcare
Industry Diagnostics & Research
Offical website >
 
EXAS Address
EXAS
 
EXAS Latest News
 
Your Comments and Response on Exact Sciences Corporation
 
EXAS Business Profile
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype MAP, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin. Address: 5505 Endeavor Lane, Madison, WI, United States, 53719
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service